Using skeletal muscle as an artificial endocrine tissue

Journal of Endocrinology

Volumn 162, Issue 1, 1999, Pages 1-9

  MacColl, G S ^a   Goldspink, C ^a   Bouloux, P M G ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GROWTH HORMONE;

CLONING VECTOR; DIABETIC NEUROPATHY; FABRY DISEASE; GENE TARGETING; GLOMERULONEPHRITIS; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; MOTOR NEURON DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; REVIEW; SKELETAL MUSCLE; TRANSGENE;

GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MUSCLE, SKELETAL;

EID: 0032791503     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1620001     Document Type: Review

References (70)

1. Aihara H & Miyazaki J 1998 Gene transfer into muscle by electroporation in vivo. Nature Biotechnology 16 867-870.
2. Al-Hendy A, Hortelano G, Tannenbaum GS & Chang PL 1995 Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - an alternative approach to somatic gene-therapy. Human Gene Therapy 6 165-175.
3. Anwer K, Shi M, French MF, Muller SR, Chen W, Liu QS, Proctor BL, Wang JJ, Mumper RJ, Singhal A, Rolland AP & Alila HW 1998 Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine. Human Gene Therapy 9 659-670.
4. Apfel SC & Kessler JA 1996 Neurotrophic factors in the treatment of peripheral neuropathy. CIBA Foundation Symposia 196 98-108.
5. Barry MA, Lai WC & Johnston SA 1995 Protection against mycoplasma infection using expression library immunisation. Nature 377 632-635.
6. Battegay EJ 1995 Angiogenesis-mechanistic insights, neovascular diseases, and therapeutic prospects. Journal of Molecular Medicine 73 333-346.
7. Bluepajot MT, Epelbaum J, Gourdji D, Hammond C & Kordon C 1998 Hypothalamic and hypophyseal regulation of growth hormone secretion. Cellular and Molecular Neurobiology 18 101-123.
8. Bohl D, Naffakh N & Heard JM 1997 Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nature Medicine 3 299-305.
9. Border WA & Noble NA 1995 Targeting TGF beta for treatment of disease. Nature Medicine 1 1000-1001.
10. Cedarbaum JM, Chapman C, Charatan M, Stambler N, Andrews L, Zhan C, Radka S, Momsey D, Lakings D, Brooks BR, Sanjak M, Pestronk A, Florence J, Mitsumoto H, Szirony K, Bittle L, Neville H, Ringel S, Brinkmann J & Wittes J 1995 A phase-1 study of recombinant human ciliary neurotrophic factor (rhCNTF) in patients with amyotrophic lateral sclerosis. Clinical Neuropharmacology 18 515-532.
11. Coleman M, Rabinovsky E, Liu Q, Kattash M, Wang J & Alila H 1998 Non-viral IGFI gene therapy slows development of motor neuropathy in diabetic mice. (In Press).
12. Danko I & Wolff JA 1994 Direct gene-transfer into muscle. Vaccine 12 1499-1502.
13. Danko I, Williams P, Herweijer H, Zhang G, Latendresse JS, Bock I & Wolff JA 1997 High expression of naked plasmid DNA in muscles of young rodents. Human Molecular Genetics 6 1435-1443.
14. Davis HL, Demeneix BA, Quantin B, Coulombe J & Whalen RG 1993 Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Human Gene Therapy 4 733-740.
15. Davis HL, Mccluskie MJ, Gerin JL & Purcell RH 1996 DNA Vaccine for hepatitis B - evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proceedings of the National Academy of Sciences of the USA 93 7213-7218.
16. Desnick RJ & Bishop DF 1995 Fabry Disease and α-Galactosidase Deficiency. In The Metabolic Bases for Inherited Disease, pp 2741-2784. Eds Scriver CR, Beaudet AL, Sly WS & Valle D. New York: McGraw-Hill.
17. DeVlam K, de Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, d'Haese D & Veys EM 1993 Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clinical and Experimental Rheumatology 11 393-397.
18. Draghiaakli R, Li XY & Schwartz RJ 1997 Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector. Nature Biotechnology 15 1285-1289.
19. Feldman LJ, Tahlil O & Steg G 1996 Perspectives of arterial gene-therapy for the prevention of restenosis. Cardiovascular Research 32 194-207.
20. Fischman D 1972 Development of Striated Muscle. In The Structure and Function of Muscle, edn 2, pp 75-142. Ed GH Bourne. New York: Academic Press Inc.
21. Fisher KJ, Jooss K, Alston J, Yang YP, Haeker SE, High K, Pathak R, Raper SE & Wilson JM 1997 Recombinant adeno-associated virus for muscle directed gene therapy. Nature Medicine 3 306-312.
22. Floyd SS, Booth DK, van Deukekom JCT, Day CS & Huard J 1997 Autologous myoblast transfer: a combination of myoblast transplantation and gene therapy. Basic and Applied Myology 7 241-250.
23. Gabrilovich DI, Chen HL, Cunninham HT, Meny GM, Nadaf S, Kavanaugh D & Carbone DP 1996 Production of vascular endothelial growth-factor by human tumours inhibits the functional maturation of dendritic cells. Nature Medicine 2 1096-1103.
24. Gorecki DC & MacDermot KD 1997 Gene therapy: panacea or placebo? II. Main applications of gene therapy. Archivum Immunologiae et Therapiae Experimentalis 45 367-374.
25. Gregoriadis G, Saffie R & deSouza JB 1997 Liposome-mediated DNA vaccination. FEBS Letters 402 107-110.
26. Haase G, Kennel P, Vigne E, Akli S, Revah F, Schmalbruch H & Kahn A 1996 Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Medicine 3 429-436.
27. Hahn TM, Copeland KC & Woo SLC 1996 Phenotypic correction of dwarfism by constitutive expression of growth hormone. Endocrinology 137 4988-4993.
28. Hu SX, Ji W, Zhou YL, Logothetis C & Xu HJ 1997 Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Research 57 3339-3343.
29. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA & Border WA 1996 Gene-therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Medicine 2 418-423.
30. Ishii DN & Lupien SB 1995 Insulin-like growth factors protect against diabetic neuropathy - effects on sensory nerve regeneration in rats. Journal of Neuroscience 40 138-144.
31. Johnson IP, Skarli M, Goldspink G, Erabadda P, Coffin RS, Wagstaff M & Latchman DS 1998 Comparison of plasmid and viral DNA for the transfer of genes to motor neurones. (In Press).
32. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S & Caskey CT 1996 A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proceedings of the National Academy of Sciences of the USA 93 5731-5736.
33. Lepantalo M & Tukianen E 1996 Combined vascular reconstruction and microvascular muscle flap transfer for salvage of ischemic legs with major tissue loss and wound complications. European Journal of Vascular and Endovascular Surgery 12 65-69.
34. Liang X, Hartika J, Sukhu L, Manthorpe M & Hobart P 1996 Novel high expressing and antibiotic controlled plasmid vectors designed for use in gene therapy. Gene Therapy 3 350-356.
35. MacColl G, Novo J, Marshall N, Goldspink G & Bouloux P 1998 A method for producing biologically active growth hormone in muscle cells. Journal of Endocrinology 156 (Suppl) OC 20.
36. McGary EC, Rondon IJ & Beckman BS 1997 Post-transcriptional regulation of erythropoietin mRNA stability by erythropoietin mRNA-binding protein. Journal of Biological Chemistry 272 8628-8634.
37. Miller G, Steinbrecher RA, Murdock PJ, Tuddenham EGD, Lee CA, Pasi KJ & Goldspink G 1995 Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer - modelling gene therapy for hemophilia. Gene Therapy 2 736-742.
38. Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Lanctot AM, Greco CM, Steinman L & Blau HM 1997 Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle and Nerve 20 469-478.
39. Morsy MA, Gu MC, Motzel S, Zhao J, Su Q, Allen H, Franlin L, Parks RJ, Graham FL, Kochanek S, Bett AJ & Caskey CT 1998 An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proceedings of the National Academy of Sciences of the USA 95 7866-7871.
40. Mumper RJ, Wang JJ, Klakamp SL, Nitta H, Anwer K, Tagliaferri F & Rolland AP 1998 Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. Journal of Controlled Release 52 191-203.
41. Ng ST, Zhou JA, Adesanya OO, Wang J, LeRoith D & Bondy CA 1997 Growth hormone treatment induces mammary gland hyperplasia in ageing. Nature Medicine 3 1141-1149.
42. Novo FJ, Gorecki DC, Goldspink G & MacDermot KD 1997 Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo. Gene Therapy 4 488-492.
43. Ohshimi T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, Sugimoto Y, Pastan I, Gottesman MM & Brady RO 1997 Alpha-galactosidase A deficient mice: a model of Fabry disease. Proceedings of the National Academy of Sciences of the USA 94 2540-2544.
44. Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP & Gabrilovich DI 1998 Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic cells. Journal of Immunology 160 1224-1232.
45. Petrof BJ 1998 The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Molecular and Cellular Biochemistry 179 111-123.
46. Pin CL & Merrifield PA 1997 Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Developmental Biology 188 147-166.
47. Rask CA, Carlsen RC & Elias KA 1998 Site of action of recombinant human nerve growth factor (rhNGF) in diabetic neuropathy appears to be small sensory neurons in the peripheral nervous system: phase II data support clinical results. Journal of Endocrinology 156 (Suppl) P91.
48. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F, Holt DA & Gilman M 1996 A humanised system for pharmacological control of gene expression. Nature Medicine 2 1028-1032.
49. Roman M, Martin-Orozco E, Goodman JS, Nguyen M-D, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA & Raz E 1997 Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Medicine 3 849-854.
50. Rothmann T, Katus HA, Hartong R, Perricaudet M & Fransz WM 1996 Heart muscle-specific gene-expression using replication-defective recombinant adenovirus. Gene Therapy 3 919-926.
51. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA & Raz E 1996 Immunostimulatory DNA sequences necessary for effective intradermal gene immunizations. Science 272 352-354.
52. Scadding JW & Gibbs J 1994 Neurological disease. In Textbook of Medicine, edn 2, pp 858-982. Eds RL Souhami & J Moxham. Edinburgh: Churchill Livingstone.
53. Skarli M, Kiri A, Vrbova G, Lee CA & Goldspink G 1998 Myosin regulatory elements as vectors for gene transfer by intramuscular injection. Gene Therapy 5 514-520.
54. Sporn MB & Roberts AB 1992 Transforming growth factor beta -recent progress and new challenges. Journal of Cell Biology 119 1017-1021.
55. Stacey KJ, Sweet MJ & Hume DA 1996 Macrophages ingest and are activated by bacterial DNA. Journal of Immunology 157 2116-2122.
56. Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM & Symes JF 1994 Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of limb ischaemia. Circulation 90 228-243.
57. Tripathy SK, Goldwasser E, Lu MM, Barr E & Leiden JM 1994 Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-deficient adenovirus. Proceedings of the National Academy of Sciences of the USA 91 11557-11561.
58. Tripathy SK, Black HB, Goldwasser E & Leiden M 1996 Immune responses to transgene encoded proteins limit the stability of gene expression after injection of replication defective adenovirus vectors. Nature Medicine 2 545-550.
59. Vile RG, Sunassee K & Diaz RM 1998 Strategies for achieving multiple layers of selectivity in gene therapy. Molecular Medicine Today 4 84-92.
60. Waine GJ & McManus DP 1995 Nucleic acids - vaccines of the future. Parasitology Today 11 113-116.
61. Wang J-M, Zheng H, Sugahara Y, Tan J, Yao SN, Olson E & Kurachi K 1996 Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells. Human Gene Therapy 7 1743-1756.
62. Wells DJ & Goldspink G 1992 Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle. FEBS Letters 306 203-205.
63. Wells KE, Maule J, Kingston R, Foster K, McMahon J, Damien E, Poole A & Wells DJ 1997 Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle. FEBS Letters 407 164-168.
64. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A & Felgner PL 1990 Direct-gene transfer into mouse muscle in vivo. Science 247 1465-1468.
65. Yamaguchi Y, Mann DM & Ruoslahti E 1990 Negative regulation of transforming growth factor beta by the proteoglycan decorin. Nature 346 281-284.
66. Yang YP, Trinchieri G & Wilson JM 1995 Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene-therapy to mouse lung. Nature Medicine 1 890-893.
67. Yang Y, Haeker SE, Su Q & Wilson JM 1996 Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Human Molecular Genetics 5 1703-1712.
68. Yao SN, Wilson JM, Nabel EG, Kurachi S, Hdachiya HL & Kurachi K 1991 Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for haemophilia B. Proceedings of the National Academy of Sciences of the USA 88 8101-8105.
69. Yeh P & Perricaudet M 1997 Advances in adenoviral vectors: from genetic engineering to their biology. FASEB Journal 11 615-623.
70. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE & Welsh MJ 1993 Adenovirus-mediated gene - transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75 207-216.